Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population

NCT04561102 is registered in ClinicalTrials.gov with Illumina, Inc. as lead sponsor.

NCT NCT04561102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04561102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population
Lead sponsor
Illumina, Inc.
Phase
Observational
Overall status
Completed
Start date
September 11, 2020
Completion date
February 28, 2021
Enrollment
644 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2